首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

1560807

全球多參數病患監護設備市場 - 2024 - 2031

Global Multiparameter Patient Monitoring Devices Market - 2024 - 2031

出版日期: 2024年09月23日 | 出版商:

DataM Intelligence | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

全球多參數病患監護設備市場在 2023 年達到 111.9 億美元，預計到 2031 年將達到 233 億美元，2024-2031 年預測期間複合年成長率為 9.6%。

多參數患者監護設備是必不可少的醫療儀器，使醫療保健專業人員能夠同時監測多種生命徵象，例如心率、血壓、呼吸頻率、血氧飽和度和體溫。這些設備旨在提供即時資料，這對於做出明智的臨床決策、增強患者安全和改善整體護理服務至關重要。

多參數患者監護設備是現代醫療保健中的重要工具，可以連續、即時地追蹤生命徵象。這些多功能設備在醫院和居家護理環境中都是不可或缺的，在改善病患治療效果方面發揮關鍵作用。

市場動態：

司機

慢性病發生率上升和技術進步

全球多參數患者監護設備市場的需求是由多種因素所驅動的。主要因素之一是慢性病發病率上升和技術進步。非傳染性疾病 (NCD) 發病率的上升已成為緊迫的公共衛生問題，需要有效的監測解決方案來管理這些長期疾病，其中包括心血管疾病、糖尿病、慢性呼吸道疾病和癌症等疾病。

根據世界衛生組織 2023 年 9 月的資料，非傳染性疾病 (NCD) 是一個重大的全球健康問題，每年導致約 4,100 萬人死亡，佔全球死亡人數的 74%。對更好的疾病管理策略的需求不斷成長，導致多參數監測設備市場不斷成長，這些設備可以同時追蹤多個生命徵象以提供全面的患者資料。

穿戴式科技、人工智慧和資料分析的進步極大地增強了多參數監視器的功能。無線連接以及與電子健康記錄 (EHR) 的無縫整合等功能提高了這些設備的性能和用戶體驗，從而增加了它們對醫療保健提供者的吸引力。

此外，關鍵參與者的策略（例如夥伴關係和協作以及創新產品發布）推動了該市場的成長。例如，2023 年 11 月，BioIntelliSense 與加州大學戴維斯分校健康中心合作，為接受骨髓移植和血液學/腫瘤學服務的患者推出了一項新的院內監測計畫。這項創新計畫利用 BioIntelliSense 經 FDA 批准的 BioButton 穿戴式設備，以及演算法資料分析和臨床智慧系統，來監測生命徵象趨勢的細微變化並檢測潛在的患者病情惡化。

此外，2023 年 5 月，Vivalink 宣布了其多參數穿戴式心電圖貼片的最新版本，具有連續 14 天的直播功能。這款創新貼片透過單一應用程式實現長時間監測，徹底改變了遠端心電圖監測，顯著減輕了臨床醫生和患者的負擔。

限制

嚴格的監管框架、設備成本高、資料安全和隱私問題以及缺乏適當報銷等因素預計將阻礙市場發展。

細分市場分析

全球多參數患者監護設備市場根據設備類型、嚴重程度、年齡層、目標區域以及最終用戶和地區進行細分。

攜帶式|緊湊型設備細分市場約佔全球多參數患者監護設備市場佔有率的 68.2%

預計攜帶式/緊湊型設備領域將在預測期內佔據最大的市場佔有率。攜帶式多參數患者監護設備旨在測量和顯示多種生命徵象，包括心率、血壓、呼吸頻率、氧飽和度和溫度，所有這些都採用緊湊的移動設計。攜帶式監視器提供了增強的靈活性和移動性，使醫療保健提供者能夠在醫院、門診診所和家庭護理環境等不同環境中監測患者。

攜帶式多參數監視器專為方便用戶使用性而設計，使醫療保健專業人員能夠在醫院病房或各種醫療保健環境中輕鬆移動它們。其輕巧緊湊的設計提高了患者的舒適度和移動性，方便了護理服務，而無需將患者限制在醫院病床上。遠距醫療服務的成長顯著增加了對攜帶式監測設備的需求。這些設備可以輕鬆地將患者資料遠距離發送給醫療保健提供者，從而實現持續監控並支援虛擬諮詢。這種整合提高了患者的參與度並實現了健康狀況的主動管理。

此外，該行業的主要參與者推出了創新平台和攜帶式設備的關鍵發展，推動了該市場的成長。例如，2024 年 1 月，Blue Spark Technologies, Inc. 推出了 VitalTraq，這是一個創新的多感測器遠端患者監護平台。此創新平台採用最先進的非接觸式生命徵象測量感測器之一－遠端光電體積描記法 (rPPG)。透過 30 至 60 秒的快速自拍掃描，患者、臨床醫生和研究人員可以獲得心率、心率變異性、血壓和呼吸頻率等生命徵象的數位測量結果，所有這些都在一次非接觸式體驗中完成。

同樣，2024 年 1 月，Pylo Health 宣布推出兩款先進的病患設備：Pylo 900-LTE 血壓監測儀和 Pylo 200-LTE 體重計。這兩款設備都經過了臨床驗證，旨在連接到多個蜂窩網路，確保在美國各地進行可靠的資料傳輸。 Pylo 900-LTE和200-LTE與Prevounce遠端護理管理平台相容，還可透過Pylo雲端API與各種獨立健康應用和管理系統整合。

市場地理分析

北美約佔全球多參數患者監護設備市場佔有率的43.2%

由於北美人口老化的加劇是推動多參數患者監護設備市場成長的關鍵因素，預計北美地區將在預測期內佔據最大的市場佔有率。隨著越來越多的人步入老年，慢性病的盛行率上升，需要持續監測以有效管理他們的健康狀況。

根據人口資料局2024年1月的資料，到2050年，美國將有約8,900萬公民年齡在65歲以上。美國心臟協會表示，美國約有 4,000 萬 65 歲及以上的人患有心血管疾病。老年人慢性病負擔的增加是推動多參數監測設備需求的重要因素。

此外，大量關鍵參與者的存在、先進的醫療保健基礎設施、關鍵參與者的策略（例如夥伴關係和協作）、技術進步以及產品發布和批准將推動該地區的市場成長。例如，2023 年 10 月，邁瑞與 Edwards Lifesciences 的合作達到了一個重要里程碑，Edwards Lifesciences 是結構性心臟病和重症監護監測醫療解決方案的頂級創新者。這一里程碑使邁瑞的 BeneVision N 系列成為北美市場上第一個與 Edwards FloTrac 感測器整合用於血流動力學監測的患者監測系統。

此外，2023 年 6 月，皇家飛利浦宣布獲得 FDA 批准，可以在飛利浦的 IntelliVue MX750 和 MX850 患者監視器中啟用 SedLine 腦功能監測、區域血氧測定 (O3) 和 CO2 測量。這項進展標誌著兩家公司之間持續合作的最新階段，旨在使臨床醫生能夠在不需要額外監測設備的情況下做出快速、明智的決策。整合這些先進的監測功能將使醫療保健提供者能夠使用單一監測器評估腦血飽和度、麻醉鎮靜和呼吸性能，從而提高患者護理的效率和成本效益。

Multiparameter patient monitoring devices are essential medical instruments that enable healthcare professionals to monitor multiple vital signs simultaneously, such as heart rate, blood pressure, respiratory rate, oxygen saturation, and temperature. These devices are designed to provide real-time data, which is crucial for making informed clinical decisions, enhancing patient safety, and improving overall care delivery.

Multiparameter patient monitoring devices are essential tools in modern healthcare that enable continuous, real-time tracking of vital signs. These versatile devices are indispensable in both hospital and home care settings, playing a critical role in improving patient outcomes.

Market Dynamics: Drivers

Rising incidence of chronic diseases and technological advancements

The demand for the global multiparameter patient monitoring devices market is driven by multiple factors. One of the primary factors is the rising incidence of chronic diseases and technological advancements. The rising incidence of noncommunicable diseases (NCDs) has become a pressing public health concern, necessitating effective monitoring solutions for managing these long-term illnesses, which include conditions such as cardiovascular diseases, diabetes, chronic respiratory diseases, and cancers.

As per WHO data in September 2023, noncommunicable diseases (NCDs) pose a major global health issue, responsible for around 41 million deaths annually, which accounts for 74% of all fatalities worldwide. This increasing demand for better disease management strategies has led to a growing market for multiparameter monitoring devices, which can track multiple vital signs simultaneously to provide comprehensive patient data.

Advancements in wearable technology, artificial intelligence, and data analytics have greatly enhanced the functionality of multiparameter monitors. Features like wireless connectivity and seamless integration with electronic health records (EHRs) improve the performance and user experience of these devices, increasing their attractiveness to healthcare providers.

Moreover, key player's strategies such as partnerships & collaborations, and innovative product launches drive this market growth. For instance, in November 2023, BioIntelliSense, partnered with UC Davis Health in California to launch a new in-hospital monitoring initiative for patients undergoing Bone Marrow Transplant and Hematology/Oncology services. This innovative program utilizes BioIntelliSense's FDA-cleared BioButton wearable devices, along with algorithmic data analytics and a clinical intelligence system, to monitor subtle changes in vital sign trends and detect potential patient deterioration.

Also, in May 2023, Vivalink announced the latest iteration of its multi-parameter wearable ECG patch, featuring continuous 14-day live streaming capabilities. This innovative patch revolutionizes remote ECG monitoring by enabling extended-duration monitoring with a single application, significantly reducing the burden on both clinicians and patients.

Restraints

Factors such as the stringent regulatory framework, high cost of devices, data security and privacy concerns, and lack of proper reimbursement are expected to hamper the market.

Market Segment Analysis

The global multiparameter patient monitoring devices market is segmented based on device type, acuity level, age group, target area, and end-user and region.

The portable|compact devices segment accounted for approximately 68.2% of the global multiparameter patient monitoring devices market share

The portable/compact devices segment is expected to hold the largest market share over the forecast period. Portable multiparameter patient monitoring devices are engineered to measure and display several vital signs, including heart rate, blood pressure, respiratory rate, oxygen saturation, and temperature, all within a compact and mobile design. Portable monitors offer enhanced flexibility and mobility, allowing healthcare providers to monitor patients across diverse settings such as hospitals, outpatient clinics, and home care environments.

Portable multiparameter monitors are built for user-friendliness, enabling healthcare professionals to move them effortlessly within hospital wards or across various healthcare settings. Their lightweight and compact design improves patient comfort and mobility, facilitating care delivery without requiring patients to remain confined to a hospital bed. The growth of telehealth services has significantly increased the demand for portable monitoring devices. These devices can effortlessly send patient data to healthcare providers from a distance, allowing for ongoing monitoring and supporting virtual consultations. This integration boosts patient engagement and enables proactive management of health conditions.

Moreover, key players in the industry introducing innovative platforms and key developments in portable devices driving this market growth. For instance, in January 2024, Blue Spark Technologies, Inc., is launching VitalTraq, An innovative multi-sensor remote patient monitoring platform. This innovative platform features one of the most advanced contactless vital sign measurement sensors available, Remote Photoplethysmography (rPPG). With a quick 30 to 60-second selfie scan, patients, clinicians, and researchers can obtain digital measurements of vital signs such as heart rate, heart rate variability, blood pressure, and respiratory rate, all in a single contactless experience.

Similarly, in January 2024, Pylo Health announced the launch of two advanced patient devices the Pylo 900-LTE blood pressure monitor and the Pylo 200-LTE weight scale. Both devices have undergone clinical validation and are designed to connect to multiple cellular networks, ensuring reliable data transmission across the United States. The Pylo 900-LTE and 200-LTE are compatible with the Prevounce remote care management platform and can also integrate with various independent health applications and management systems through the Pylo cloud API.

Market Geographical Analysis

North America accounted for approximately 43.2% of the global multiparameter patient monitoring devices market share

North America region is expected to hold the largest market share over the forecast period owing to the increasing aging population in North America is a key factor driving the growth of the multiparameter patient monitoring devices market. As more individuals reach older age, the prevalence of chronic diseases rises, creating a need for ongoing monitoring to effectively manage their health conditions.

According to Population Reference Bureau data in January 2024, by 2050, approximately 89 million citizens in the United States will be over the age of 65. Conditions such as cardiovascular diseases, diabetes, and respiratory disorders are increasingly prevalent among the elderly population. The American Heart Association has indicated that approximately 40 million individuals aged 65 and older in the U.S. are affected by cardiovascular diseases. This rising burden of chronic illnesses in older adults is a significant factor driving the demand for multiparameter monitoring devices.

Moreover, a major number of key players' presence, well-advanced healthcare infrastructure, key players' strategies such as partnerships & collaborations, technological advancements, and product launches & approvals would propel this market growth in this region. For instance, in October 2023, Mindray reached a significant milestone in its partnership with Edwards Lifesciences, a top innovator in medical solutions for structural heart disease and critical care monitoring. This milestone establishes Mindray's BeneVision N-Series as the first patient monitoring system in the North American market to integrate with Edwards' FloTrac sensor for hemodynamic monitoring.

Also, in June 2023, Royal Philips announced that they received FDA clearance to enable SedLine Brain Function Monitoring, Regional Oximetry (O3), and CO2 measurements in Philips' IntelliVue MX750 and MX850 patient monitors. This development marks the latest phase in the ongoing collaboration between the two companies, aimed at empowering clinicians to make swift and informed decisions without requiring additional monitoring devices. Integrating these advanced monitoring capabilities will allow healthcare providers to assess brain blood saturation, anesthetic sedation, and respiratory performance using a single monitor, enhancing the efficiency and cost-effectiveness of patient care.

Market Segmentation

By Device Type

Portable/Compact Devices

Fixed Devices

By Acuity Level

High Acuity Level

Mid Acuity Level

Low Acuity Level

By Age Group

Pediatric

Adult

Geriatric

By Target Area

Cardiology

Neurology

Respiratory

Fetal and Neonatal

Temperature Monitoring

Others

By End-User

Hospitals

Ambulatory Surgical Centers (ASCs)

Homecare Settings

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the multiparameter patient monitoring devices market include Koninklijke Philips N.V., Medtronic, GE HealthCare, Baxter, SternMed GmbH, Dragerwerk AG & Co. KGaA, Masimo, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., ICU Medical, Inc., and Schiller among others.

Key Developments

In June 2024, Prevounce Health, a leading provider of remote care management software, devices, and services, launched its first remote blood glucose monitoring device, the Pylo GL1-LTE. This clinically validated blood glucose meter connects to multiple cellular networks to ensure reliable data transmission throughout the United States. The GL1-LTE is designed for use with the Prevounce remote care management platform and can seamlessly integrate with other health software through the Pylo cloud API. Prevounce's range of Pylo cellular-connected devices also includes blood pressure monitors and weight scales.

In October 2023, Masimo received FDA de novo clearance to incorporate the Oxygen Reserve Index (ORi) calculations into its pulse oximeters, marking a significant advancement in noninvasive patient monitoring. The ORi is designed to provide continuous, real-time insights into a patient's oxygenation status, particularly in the moderate hyperoxic range, which is crucial for patients receiving supplemental oxygen during surgical procedures.

Why Purchase the Report?

To visualize the global multiparameter patient monitoring devices market segmentation based on device type, acuity level, age group, target area, and end-user and region, and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the multiparameter patient monitoring devices market with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The global multiparameter patient monitoring devices market report would provide approximately 78 tables, 75 figures, and 184 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Device Type
3.2. Snippet by Acuity Level
3.3. Snippet by Age Group
3.4. Snippet by Target Area
3.5. Snippet by End-User
3.6. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Incidence of Chronic Diseases and Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Stringent Regulatory Framework
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Device Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 6.1.2. Market Attractiveness Index, By Device Type
6.2. Portable/Compact Devices *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Fixed Devices

7. By Acuity Level

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Acuity Level
- 7.1.2. Market Attractiveness Index, By Acuity Level
7.2. High Acuity Level *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Mid Acuity Level
7.4. Low Acuity Level

8. By Age Group

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 8.1.2. Market Attractiveness Index, By Age Group
8.2. Pediatric *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Adult
8.4. Geriatric

9. By Target Area

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Area
- 9.1.2. Market Attractiveness Index, By Target Area
9.2. Cardiology *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Neurology
9.4. Respiratory
9.5. Fetal and Neonatal
9.6. Temperature Monitoring
9.7. Others

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Ambulatory Surgical Centers (ASCs)
10.4. Homecare Settings
10.5. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Acuity Level
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Area
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.8.1. U.S.
  - 11.2.8.2. Canada
  - 11.2.8.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Acuity Level
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Area
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.8.1. Germany
  - 11.3.8.2. U.K.
  - 11.3.8.3. France
  - 11.3.8.4. Spain
  - 11.3.8.5. Italy
  - 11.3.8.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Acuity Level
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Area
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.8.1. Brazil
  - 11.4.8.2. Argentina
  - 11.4.8.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Acuity Level
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Area
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.8.1. China
  - 11.5.8.2. India
  - 11.5.8.3. Japan
  - 11.5.8.4. South Korea
  - 11.5.8.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Acuity Level
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Area
- 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Koninklijke Philips N.V.*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Medtronic
13.3. GE HealthCare
13.4. Baxter
13.5. SternMed GmbH
13.6. Dragerwerk AG & Co. KGaA
13.7. Masimo
13.8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.9. ICU Medical, Inc.
13.10. Schiller (*LIST NOT EXHAUSTIVE)